The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

被引：0
|
作者：
Carvalho, Julia [1 ]
Cupello, Mauricio [2 ]
Medina, Romulo [2 ]
机构：
[1] INCA, Rio De Janeiro, Brazil
[2] Unigranrio, Rio De Janeiro, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CAR-T; CRISPR/Cas9; Brazil; gene editing; universal CAR-T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-312
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [21] A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
    Al Saber, Md.
    Biswas, Partha
    Dey, Dipta
    Abu Kaium, Md.
    Islam, Md. Aminul
    Tripty, Miss Ismoth Ara
    Rahman, MD. Hasanur
    Rahaman, Tanjim Ishraq
    Biswas, Md. Yeaman
    Paul, Priyanka
    Rahman, Md. Ataur
    Hasan, Md. Nazmul
    Kim, Bonglee
    PROCESSES, 2022, 10 (01)
  • [22] Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology
    Khajuria, Ocean
    Sharma, Neha
    Vaishno, Shri Mata
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2021, 3
  • [23] GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
    Caforio, M.
    Iacovelli, S.
    Quintarelli, C.
    Locatelli, F.
    Folgiero, Valentina
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [24] GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
    M Caforio
    S Iacovelli
    C Quintarelli
    F Locatelli
    Valentina Folgiero
    Journal of Experimental & Clinical Cancer Research, 43
  • [25] Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
    Sharma, Aditya Kumar
    Giri, Anil K.
    FRONTIERS IN GENETICS, 2024, 15
  • [26] CRISPR/Cas9 advances engineering of microbial cell factories
    Jakociunas, Tadas
    Jensen, Michael K.
    Keasling, Jay D.
    METABOLIC ENGINEERING, 2016, 34 : 44 - 59
  • [27] CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
    Liu, Xiaojun
    Zhao, Yangbing
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 39 - 42
  • [28] CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
    Salas-Mckee, January
    Kong, Weimin
    Gladney, Whitney L.
    Jadlowsky, Julie K.
    Plesa, Gabriela
    Davis, Megan M.
    Fraietta, Joseph A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1126 - 1132
  • [29] CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
    Chen, Chen
    Wang, Zehua
    Qin, Yanru
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [30] CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
    Chen Chen
    Zehua Wang
    Yanru Qin
    Experimental Hematology & Oncology, 12
12345